Dr. Tap on Olaratumab in Patients With Soft Tissue Sarcoma
1 vistas
• 07/18/23
0
0
Empotrar
administrator
Suscriptores
William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the mechanism of action of olaratumumab as a treatment for patients with soft tissue sarcoma.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios